Drugs / Kanarine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04482803 | Sep 2020 → Dec 2022 | axillary neoplasm | The First Affiliated Hospital with Nanjing Medical University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kanarine | “a small amount of Kanarine (Carbon Nanoparticles Suspension Injection, 0.5ml:25mg, H20073246) will be injected into or around the cortex of the locating lymph node” NCT04482803 ↗ |
| Known as | Carbon Nanoparticles Suspension Injection | “a small amount of Kanarine (Carbon Nanoparticles Suspension Injection, 0.5ml:25mg, H20073246) will be injected into or around the cortex of the locating lymph node” NCT04482803 ↗ |
| Route | Other | “will be injected into or around the cortex of the locating lymph node and other clinically assessed positive lymph nodes” NCT04482803 ↗ |